Abeona Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABEO and other ETFs, options, and stocks.About ABEO
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB).
CEOVishwas Seshadri
CEOVishwas Seshadri
Employees136
Employees136
HeadquartersCleveland, Ohio
HeadquartersCleveland, Ohio
Founded1974
Founded1974
Employees136
Employees136
ABEO Key Statistics
Market cap211.52M
Market cap211.52M
Price-Earnings ratio6.91
Price-Earnings ratio6.91
Dividend yield—
Dividend yield—
Average volume2.03M
Average volume2.03M
High today$4.70
High today$4.70
Low today$4.13
Low today$4.13
Open price$4.36
Open price$4.36
Volume881.70K
Volume881.70K
52 Week high$7.54
52 Week high$7.54
52 Week low$3.93
52 Week low$3.93
Stock Snapshot
The current Abeona Therapeutics(ABEO) stock price is $4.13, with a market capitalization of 211.52M. The stock trades at a price-to-earnings (P/E) ratio of 6.91.
As of 2025-11-06, Abeona Therapeutics(ABEO) stock has fluctuated between $4.13 and $4.70. The current price stands at $4.13, placing the stock 0.0% above today's low and -12.3% off the high.
The Abeona Therapeutics(ABEO)'s current trading volume is 881.7K, compared to an average daily volume of 2.03M.
In the last year, Abeona Therapeutics(ABEO) shares hit a 52-week high of $7.54 and a 52-week low of $3.93.
In the last year, Abeona Therapeutics(ABEO) shares hit a 52-week high of $7.54 and a 52-week low of $3.93.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ABEO. This list is generated using Robinhood data, and it’s not a recommendation.